Loading clinical trials...
Loading clinical trials...
This multi-center, prospective, observational study will describe the management of relapsing or refractory chronic lymphocytic leukemia (CLL) patients. Data will be collected for 2 years.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT02242942 · Lymphocytic Leukemia, Chronic
NCT01991184 · Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
NCT01283386 · Lymphocytic Leukemia, Chronic
NCT01292603 · Lymphocytic Leukemia, Chronic
NCT00241358 · Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, and more
Aix-en-Provence
Aix-en-Provence
Albi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions